The New York Presbyterian Hospital-Weill Medical Center
New York, 10021, United States
NCT Number: NCT00226265
The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
New York, 10021, United States
The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Weill Medical College of Cornell University
Other
The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04124120
Arterial Occlusive Diseases, Arteriosclerosis
Los Angeles, California, United States
View Trial DetailsNCT07521488
Acute Aortic Syndrome, Aneurysm
Beijing, Beijing Municipality, China
View Trial DetailsNCT00892905
Cardiovascular Diseases, Coronary Artery Bypass Grafting
Hamilton, Ontario, Canada
View Trial DetailsNCT06793436
Coronary Artery Bypass Grafting, Neurologic Manifestations
Van, Tuşba, Turkey (Türkiye)
View Trial Details